DOI: http://dx.doi.org/10.18203/2320-1770.ijrcog20185453

Camylofin dihydrochloride injection: a drug monograph review

Niranjan Mayadeo

Abstract


Camylofin dihydrochloride is an anti-spasmodic drug available in India and other Latin American and African countries, for the treatment of abdominal colic and for acceleration of labor. Although, the drug has been in use for over six decades, with multiple citations in academic text books of repute, treatment protocols, and multiple research publications, there is no consolidated published information on the pharmacology and clinical details of camylofin. This drug statement/monograph is an attempt to collate and present scientific information that will come in handy to practicing obstetricians and gynaecologists, as well as other primary care physicians, when treating cases of abdominal colic or managing prolonged labor. Approved clinical indications, clinical pharmacology, dosage, contraindications, precautions, drug interactions, adverse effects, overdose and clinical evidence in different indications are covered herein.


Keywords


Anti-spasmodic, Augmentation of labor, Camylofin, Cervical dilatation, Drotaverine, Hyoscine, Spasmolytic, Valethemate

Full Text:

PDF

References


Avacan. Available at: https://www.ndrugs.com/?s=avacan.

Camylofin. Available at: https://www.drugs.com/international/camylofin.html.

Brock N. Pharmacology of Avacan. Dtsch Med Wochenschr. 1951;76(14):474-7.

Tadashi M, Koichi Y. A study of metabolism of Isoamyl-alpa-N(beta-diethylaminoethyl) Aminophenylacetate-(Avacan). Jpn J Pharmacol. 1956;5(2):122-31.

Selected Topics in Obstetrics and Gynaecology for Postgraduates and Practitioners. Available at: https://books.google.co.in/books?id=xxpa0meEd1YCandpg=RA1-PA5anddq=anafortan+daftariandhl=enandsa=Xandved=0ahUKEwi_j_ui7JrZAhWDvo8KHau9AxwQ6AEIKDAA#v=onepageandq=anafortan%20daftariandf=false.

Shaw's Textbook of Gynecology E-Book. Available at: https://books.google.co.in/books?id=hDITBwAAQBAJandpg=PA472anddq=anafortanandhl=enandsa=Xandved=0ahUKEwiVx_DEgpvZAhWLMY8KHfhoBSAQ6AEIPTAE#v=onepageandq=anafortanandf=false.

Textbook of Obstetrics. Available at: https://books.google.co.in/books?id=RXSJDAAAQBAJandpg=PA250anddq=anafortanandhl=enandsa=Xandved=0ahUKEwiVx_DEgpvZAhWLMY8KHfhoBSAQ6AEISDAG#v=onepageandq=anafortanandf=false.

Operative Obstetrics and Gynecology. Available at: https://books.google.co.in/books?id=rLbTAwAAQBAJandpg=PA185anddq=anafortanandhl=enandsa=Xandved=0ahUKEwjvgeisg5vZAhUKo48KHafoCtk4ChDoAQg3MAI#v=onepageandq=anafortanandf=false.

Best Aid to Gynecology. Available at: https://books.google.co.in/books?id=BTkIAQAAQBAJandpg=PA257anddq=camylofinandhl=enandsa=Xandved=0ahUKEwjfxfvjg5vZAhUCaI8KHXM0Ans4FBDoAQgnMAA#v=onepageandq=camylofinandf=false.

Textbook of Gynaecology. Available at: https://books.google.co.in/books?id=OzOq3Ddfg-8Candpg=PA42anddq=camylofinandhl=enandsa=Xandved=0ahUKEwjfxfvjg5vZAhUCaI8KHXM0Ans4FBDoAQhQMAg#v=onepageandq=camylofinandf=false.

Daftary SN, Desai SV, Thanawala U, Bhide A, Levi J, Patki A, et al. Programmed labor indegenous protocol to optimize labor outcome. J South Asian Fed Obstet Gynecol. 2009;1(1):61-4.

Bachani S, Topden S. Active management of labor in a low‐resource setting and its impact on cesarean section rates. Int J Gynecol Obstet. 2006;94(1):54-5.

Mayadeo N, Gangadhar A, Das S. Camylofin in the management of prolonged labor: A review of evidence. Int J Reprod Contracept Obstet Gynecol. 2017;6(3):776-780

Camylofin. Available at: https://drugs.ncats.io/ginas/app/substance/3fea6c3d.

Unpublished Data: The Drugs Controller, India – Letter of permission to import ‘Avacan’ dated 23rd October 1958. Courtesy-Abbott Healthcare Private Limited.

Kokilambigai KS, Lakshmi KS. Camylofin dihydrocloride-a review of analytical methods. Int J Pharm Pharm Sci. 2014;6(1):36-7.

Prescribing information of Anafortan Injection. Version 1.0 Dated Jan 2016.

Gupta C. Use of Anafortan Intravenous injection for treatment of colicky pain. J Indian Med Assoc. 2000;98(8):479-80.

Brock N. Pharmacology of Avacan. Dtsch Med Wochenschr. 1951;76(14):474-7.

Warke HS, Chauhan AR, Raut VS, Ingle KM, Efficacy of camylofin dihydrochloride in acceleration of labour. A randomised double blind trial. Bombay Hospital J. 2003;l.45(3)420-3.

Kamel AH, Mahmoud WH, Mostafa MS. Selective recognition in potentiometric sensing based on two competitive recognition sites for static and hydrodynamic determination of camylofin as a smooth muscle relaxant. Eur Chem Bull. 2013;2(2):88-93.

Gray J, Wardrope J, Fothergill DJ. 7 abdominal pain, abdominal pain in women, complications of pregnancy and labour. Emerg Med J. 2004;21:606-13.

Cartwright SL, Knudson MP. Evaluation of Acute Abdominal Pain in Adults. Am Fam Physician. 2008;77(7):971-8.

Dayama SS, Patil SS, Sambarey PW. A randomised controlled study of intramuscular camylofin dihydrochloride vs intravenous hyoscine butylbromide in augmentation of labour. Global J Med Res: Gynecol Obstet. 2016;16(1):1-6.

Kaur S, Bajwa SK, Kaur P, Bhupal S. To compare the effect of camylofin dihydrochloride (anafortin) with combination of valethamate bromide (epidosin) and hyoscine butyl-n-bormide (buscopan) on cervical dilation. J Clin Diagn Res. 2013;7(9):1897-9.

Rajani U, Binu P. A randomized comparative study of intramuscular Camylofin dihydrochloride and intravenous Drotaverine hydrochloride on cervical dilatation in labor. Indian J Clinical Practice. 2015;26(6):558-63.

Kaur S, Kaur P, Bajwa SK, Kumari S, Mohi MK. To evaluate the incidence of side effects of camylofindihydrochloride with combination of valethemate bromide (epidosin) and hyoscine- N - butyl bromide (Buscopan), on mother and to look for neonatal outcome. J Med Health Sci. 2013;2(4):33-7

Kaur D, Kaur A. “Anafortan” an old drug with its newer use in acceleration of labour [abstract]. 49th All India Congress of Obstetrics and Gynaecology; 2006 January 6-9; Cochin, Kerala State, India. 2006:59.

Schvartsman S, Schvartsman C, Barsanti C. Camylofin intoxication reversed by naloxone. Lancet. 1988;332(8622):1246.

Pezold FA. Spasmolysis (Clinical experience with a new spamolytic Avacan). Dtsch Med Wochenschr. 1951;76(14):479-81

Helmut K, Krentz C. Clinical results with a new spasmolytic (Avacan). Arztl Wochensch. 1951;6(10):232-6.

Stoll HG. Clinical experiences with Avacan in urological diseases. Medizinische. 1952;20(35-36):1125-7.

Hiller J, Strauss E. Effect of Avacan on peristalsis of upper intestinal tract and on gastric secretion. Arzneimittelforschung. 1953;3(6):282-4.

Sielaff HJ. Comparative experimental studies on the effect of spasmolytics and ganglion-blocking substances (atropin, avacan, pendiomid, buscopan, banthine) on motility of the human small intestine. Z Gesamte Exp Med. 1953;120(6):599-612.

Pilz A. Clinical experience with a new spasmolytic (Avacan). Wien Med Wochenschr. 1955;105(20-21):438-9.

Hasselbacher K. Cystometric studies after administration of Avacan. Arztl Forsch. 1959;13(2):I/94-6.

Boldt W, Gocht W. The use of Avacan in speeding of delivery. Dtsch Med J. 1952;3(15-16):330-3.

Guseck E. Conservative speeding of delivery by Avacan. Schweiz Med Wochenschr. 1952;82(35):882-3.

Ascholter C. Acceleration of delivery by Avacan. Medizinische. 1953;36:1164-6.

Drescher H. Experience with the spasmolyticum Avacan in obstetrics. Munch Med Wochenschr. 1954;96(40):1164-5.

Jann R. Experience with the spasmolytic Avacan in obstetrics. Ther Umsch. 1954;11(4):80-2.

Etterich M, Mall-Haefeli M. The effect of spasmolytic agent on parturition. Gynaecol. 1959;147:512-21.

Rehsteiner HP. Comparative study on the labor-analgesic effect of Vendal and Centralgin-Avacan. Ther Umsch. 1962;19:348-53.

Auclair JM, Anton JP, Bellocq J, Zylberberg B. Study of the action of the association of glyceric ether of guaiacol and camylofine on the dilatation of the cervix during the labor. Rev Fr Gynecol Obstet. 1970;65(9):523-8.